إعلان
إعلان
KURA
Kura Oncology, Inc.
9.39
USDبرعاية
-0.16
-1.64%
٠٩ يناير, ١٥:٥٩ UTC -5
مغلق
بعد الإغلاق
9.49
+0.10
+1.09%
تقارير أرباح KURA
النسبة الإيجابية المفاجئة
KURA تفوق 31 من 40 آخر التقديرات.
78%
التقرير التالي
بيانات التقرير القادم
٢٤ فبراير ٢٠٢٦
Estimate for Q4 25 (Revenue/ EPS)
$85.60M
/-$0.41
التغير الضمني من Q3 25 (Revenue/ EPS)
+312.51%
/-51.76%
التغير الضمني من Q4 24 (Revenue/ EPS)
+58.85%
/+86.36%
Kura Oncology, Inc. earnings per share and revenue
On ٠٤ نوفمبر ٢٠٢٥, KURA reported earnings of -0.85 USD per share (EPS) for Q3 25, beating the estimate of -0.86 USD, resulting in a 2.16% surprise. Revenue reached 20.75 مليون, compared to an expected 42.08 مليون, with a -50.69% difference. The market reacted with a +1.94% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 16 المحللين forecast an EPS of -0.41 USD, with revenue projected to reach 85.60 مليون USD, implying an نقصان of -51.76% EPS, and زيادة of 312.51% in Revenue from the last quarter.
الأسئلة الشائعة
What were Kura Oncology, Inc.'s earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Kura Oncology, Inc. reported EPS of -$0.85, beating estimates by 2.16%, and revenue of $20.75M, -50.69% below expectations.
How did the market react to Kura Oncology, Inc.'s Q3 2025 earnings?
The stock price moved up 1.94%, changed from $9.77 before the earnings release to $9.96 the day after.
When is Kura Oncology, Inc. expected to report next?
The next earning report is scheduled for ٢٤ فبراير ٢٠٢٦.
What are the forecasts for Kura Oncology, Inc.'s next earnings report?
Based on 16
المحللين, Kura Oncology, Inc. is expected to report EPS of -$0.41 and revenue of $85.60M for Q4 2025.
Which companies are reporting earnings today?
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان